A sham-controlled, randomized trial of spinal cord stimulation for the treatment of pain in chronic pancreatitis
- PMID: 38988274
- DOI: 10.1002/ejp.2315
A sham-controlled, randomized trial of spinal cord stimulation for the treatment of pain in chronic pancreatitis
Abstract
Background: Spinal cord stimulation (SCS) has emerged as a treatment option for patients with chronic pancreatitis (CP) who experience pain that does not respond to standard interventions. However, there is a lack of sham-controlled trials to support its efficacy.
Methods: This randomized, double-blinded, sham-controlled, cross-over trial enrolled 16 CP patients with insufficient pain relief from standard therapies. Patients underwent high-frequency (1000 Hz) paraesthesia-free SCS or sham for two 10-day stimulation periods, separated by a 3-day washout period. The primary outcome was daily pain intensity registered in a pain diary based on a numeric rating scale (NRS). Secondary outcomes included various questionnaires. Quantitative sensory testing was used to probe the pain system before and after interventions.
Results: The average daily pain score on the NRS at baseline was 5.2 ± 1.9. After SCS, the pain score was 4.2 ± 2.1 compared to 4.3 ± 2.1 in the sham group (mean difference -0.1, 95% CI [-1.4 to 1.1]; P = 0.81). Similarly, no differences were observed between groups for the maximal daily pain score, secondary outcomes or quantitative sensory testing parameters. During an open-label, non-sham-controlled and non-blinded extension of the study, the average daily NRS was 5.2 ± 1.7 at baseline, 3.2 ± 1.8 at 3 months, 2.9 ± 1.9 at 6 months and 3.4 ± 2.2 at 12 months of follow-up (P = 0.001).
Conclusion: In this first sham-controlled trial of SCS in painful CP, we did not find evidence of short-term pain relief with paraesthesia-free high-frequency (1000 Hz) stimulation. However, evaluation of the long-term effect by larger sham-controlled trials with long-term follow-up is warranted.
Significance statement: In this first sham-controlled trial to apply high-frequency (1000 Hz) spinal cord stimulation in patients with visceral pain due to chronic pancreatitis, we did not find evidence for clinically relevant pain relief. Taken together with potential procedure-related complications, adverse effects and costs associated with spinal cord stimulation, our findings question its use for management of visceral pain.
© 2024 The Author(s). European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation ‐ EFIC ®.
References
REFERENCES
-
- Arendt‐Nielsen, L., Morlion, B., Perrot, S., Dahan, A., Dickenson, A., Kress, H. G., Wells, C., Bouhassira, D., & Drewes, A. M. (2018). Assessment and manifestation of central sensitisation across different chronic pain conditions. European Journal of Pain, 22, 216–241.
-
- Colloca, L. (2019). The placebo effect in pain therapies. Annual Review of Pharmacology and Toxicology, 59, 191–211.
-
- Dhruva, S. S., Murillo, J., Ameli, O., Morin, P. E., Spencer, D. L., Redberg, R. F., & Cohen, K. (2023). Long‐term outcomes in use of opioids, nonpharmacologic pain interventions, and Total costs of spinal cord stimulators compared with conventional medical therapy for chronic pain. JAMA Neurology, 80, 18–29.
-
- Drewes, a. M., Krarup, a. L., Detlefsen, S., Malmstrøm, M.‐L., Dimcevski, G., & Funch‐Jensen, P. (2008). Pain in chronic pancreatitis: The role of neuropathic pain mechanisms. Gut, 57, 1616–1627.
-
- Drewes, A. M., Bouwense, S. A. W., Campbell, C. M., Ceyhan, G. O., Delhaye, M., Demir, I. E., Garg, P. K., van Goor, H., Halloran, C., Isaji, S., Neoptolemos, J. P., Olesen, S. S., Palermo, T., Pasricha, P. J., Sheel, A., Shimosegawa, T., Szigethy, E., Whitcomb, D. C., & Yadav, D. (2017). Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology, 17, 720–731.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources